Why the study?
Does prophylactic low-dose propranolol reduce clinically important supraventricular tachyarrhythmias in patients after coronary artery bypass surgery?
Does prophylactic low-dose propranolol reduce clinically important supraventricular tachyarrhythmias in patients after coronary artery bypass surgery?
Answers are grounded in this paper and cite their sources.
Prophylactic low-dose propranolol did not significantly reduce the frequency of supraventricular tachyarrhythmias in the early postoperative period after coronary artery bypass surgery.
In the present study 75 patients were double blind randomized either to receive 10 mg propranolol orally 4 times a day (35 patients) or a placebo (40 patients). Episodes of clinically important supraventricular tachyarrhythmias were recorded in the first 4 postoperative days. They appeared in 5 of 35 patients receiving propranolol and in 5 of 40 patients receiving placebo (no statistically significant difference). In conclusion this study indicates the need for further evaluation to clarify if low-dose propranolol or any other drug is effective in reducing the frequency of SVT in the early postoperative period after coronary artery bypass surgery.
No takes yet. Share an insight, caveat, or question.
Martinussen et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: